DF
LLY icon

DecisionPoint Financial’s Eli Lilly LLY Stock Holding History

DecisionPoint Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Hold
28
– – 0.01% 122
2026
Q1 		$25.9K Hold
28
– – 0.01% 119
2025
Q4 		$30.2K Hold
28
– – 0.01% 113
2025
Q3 		$23.2K Hold
28
– – 0.01% 108
2025
Q2 		$21.8K Buy
28
+7
+33% +$5.44K 0.01% 120
2025
Q1 		$17.4K Buy
21
+5
+31% +$4.16K 0.01% 132
2024
Q4 		$12.4K Hold
16
– – ﹤0.01% 148
2024
Q3 		$14.2K Hold
16
– – ﹤0.01% 137
2024
Q2 		$12.9K Buy
16
+2
+14% +$1.6K ﹤0.01% 145
2024
Q1 		$10.3K Hold
14
– – ﹤0.01% 160
2023
Q4 		$8.16K Sell
14
-3
-18% -$1.75K ﹤0.01% 139
2023
Q3 		$9.13K Hold
17
– – ﹤0.01% 128
2023
Q2 		$7.97K Hold
17
– – ﹤0.01% 124
2023
Q1 		$5.84K Hold
17
– – ﹤0.01% 126
2022
Q4 		$6.22K Buy
+17
New +$6.03K ﹤0.01% 107

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DecisionPoint Financial's LLY Position: Q2 2026 in Review

DecisionPoint Financial held its Eli Lilly (LLY) position steady in Q2 2026 at 28 shares worth $33.6K. The position accounts for 0.01% of the portfolio, ranked #122.

DecisionPoint Financial first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DecisionPoint Financial held 28 shares of Eli Lilly worth $33.6K as of Q2 2026.
  • DecisionPoint Financial left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #122 holding.
  • DecisionPoint Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.